ANIEMEA-P-GB-202502940 | December 2025
Authors:
Nicolaas E. Deutz, Eric M. Matheson, Laura E. Matarese, Menghua Luo,
Geraldine E. Baggs, Jeffrey L. Nelson, Refaat A. Hegazi, Kelly A.
Tappenden, Thomas R. Ziegler, on behalf of the NOURISH Study Group
Publish Date:
January 2016 | 4 min
Abstract:
The NOURISH (Nutritional effect on unplanned readmissions and survival in hospitalised patients) study evaluates the impact of a high protein oral nutritional supplement (ONS) containing β-hydroxy-β-methylbutyrate (HMB) on mortality and hospital readmission rates in malnourished hospitalised older adults with a range of cardiopulmonary conditions up to 90 days post-discharge.
To read the full clinical paper, click here.
Once you have read this article, please remember to complete your self-reflective notes to contribute towards your continuing professional development. You will then be able to access your Certificate of Completion.
LEARNING OBJECTIVES
Discuss the impact of ONS on older, malnourished patients in community and hospital settings.
Assess the effects of a high protein ONS containing HMB on reducing complications, mortality and hospital readmissions.
Recognise the association between high protein ONS containing HMB, decreased post-discharge mortality and improved nutritional status.
